Show simple item record

Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on immune and cellular therapy in multiple myeloma.

dc.contributor.authorHolstein, Sarah A
dc.contributor.authorAsimakopoulos, Fotis
dc.contributor.authorAzab, Abdel Kareem
dc.contributor.authorBianchi, Giada
dc.contributor.authorBhutani, Manisha
dc.contributor.authorCrews, Leslie A
dc.contributor.authorCupedo, Tom
dc.contributor.authorGiles, Hannah
dc.contributor.authorGooding, Sarah
dc.contributor.authorHillengass, Jens
dc.contributor.authorJohn, Lukas
dc.contributor.authorKaiser, Shari
dc.contributor.authorLee, Lydia
dc.contributor.authorMaclachlan, Kylee
dc.contributor.authorPasquini, Marcelo C
dc.contributor.authorPichiorri, Flavia
dc.contributor.authorShah, Nina
dc.contributor.authorShokeen, Monica
dc.contributor.authorShy, Brian R
dc.contributor.authorSmith, Eric L
dc.contributor.authorVerona, Raluca
dc.contributor.authorUsmani, Saad Z
dc.contributor.authorMcCarthy, Philip L
dc.date.accessioned2023-10-26T15:37:37Z
dc.date.available2023-10-26T15:37:37Z
dc.date.issued2022-05-21
dc.identifier.citationHolstein SA, Asimakopoulos F, Azab AK, Bianchi G, Bhutani M, Crews LA, Cupedo T, Giles H, Gooding S, Hillengass J, John L, Kaiser S, Lee L, Maclachlan K, Pasquini MC, Pichiorri F, Shah N, Shokeen M, Shy BR, Smith EL, Verona R, Usmani SZ, McCarthy PL. Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma. Transplant Cell Ther. 2022 Aug;28(8):446-454. doi: 10.1016/j.jtct.2022.05.019. Epub 2022 May 21en_US
dc.identifier.issn2666-6375
dc.identifier.eissn2666-6367
dc.identifier.doi10.1016/j.jtct.2022.05.019
dc.identifier.pmid35605882
dc.identifier.urihttp://hdl.handle.net/20.500.14200/2708
dc.description.abstractThe Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Myeloma Intergroup conducted a workshop on Immune and Cellular Therapy in Multiple Myeloma on January 7, 2022. This workshop included presentations by basic, translational, and clinical researchers with expertise in plasma cell dyscrasias. Four main topics were discussed: platforms for myeloma disease evaluation, insights into pathophysiology, therapeutic target and resistance mechanisms, and cellular therapy for multiple myeloma. Here we provide a comprehensive summary of these workshop presentations.en_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.urlhttps://www.sciencedirect.com/journal/transplantation-and-cellular-therapy/issuesen_US
dc.rightsCopyright © 2022 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.
dc.subjectOncology. Pathology.en_US
dc.subjectHaematologyen_US
dc.titleProceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on immune and cellular therapy in multiple myeloma.en_US
dc.typeArticle
dc.source.journaltitleTransplantation and Cellular Therapy
dc.source.volume28
dc.source.issue8
dc.source.beginpage446
dc.source.endpage454
dc.source.countryUnited States
dc.source.countryUnited States
dc.source.countryUnited States
dc.source.countryUnited States
dc.source.countryUnited States
dc.source.countryUnited States
dc.source.countryUnited States
rioxxterms.versionNAen_US
dc.contributor.trustauthorGiles, Hannah
dc.contributor.departmentHaematologyen_US
dc.contributor.roleMedical and Dentalen_US
oa.grant.openaccessnaen_US


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record